Sonic Fund II, L.P.

13D and 13G Filings

Issuer % of Class Filed
Fennec Pharmaceuticals Inc. ("Issuer") 13G/A Amendment 4
FENC · 31447P100
4.5% 11/16/2026
Event 9/30/2026
Fennec Pharmaceuticals Inc. 13G/A Amendment 3
FENC · 31447P100
8.2% 2/17/2026
Event 12/31/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.